Based on recent data, Solid Biosciences Inc. (SLDB) shows an Average True Range (ATR) of 0.46 and an Enterprise Value of 283.38M. Its average trading volume over the past 3 months is 1.7M, indicating liquidity. These fundamental metrics provide insight into SLDB's underlying financial health and market activity.
| ATR | 0.46 |
| Enterprise Value | 283.38M |
| Avg Vol (3 Months) | 1.7M |
| Avg Vol (10 Days) | 1.08M |
Solid Biosciences Inc. (SLDB) technical indicators as of July 28, 2026: the SMA 20 is 0.3%, SMA 50 at 5.24%, and SMA 200 at 16.25%. The RSI 14 value is 53.03, suggesting its current momentum. These technical analysis signals help assess SLDB's price trends and potential future movements.
| SMA 20 | 0.3% |
| SMA 50 | 5.24% |
| SMA 200 | 16.25% |
| RSI 14 | 53.03 |
Solid Biosciences Inc. (SLDB) stock performance overview as of July 28, 2026: The 52-week high is $11.45 (currently -14.65% below), and the 52-week low is $3.79 (currently 161% above). Over the past year, SLDB's performance is 72.92%, compared to the S&P 500's 3.36% change.
| 52-Week High | 11.45 |
| 52-Week High Chg | -14.65% |
| 52-Week Low | 3.79 |
| 52-Week Low Chg | +161.00% |
| S&P 500 52-Week Chg | 3.36% |
According to market data, Solid Biosciences Inc. (SLDB) stock's recent performance metrics show that over the last month, SLDB is 4.46%, with a Year-to-Date (YTD) performance of -0.35%. Over the past year, the stock has seen a 72.92% change. These figures summarize SLDB's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 8.43 | 11.45 | 11.45 | 11.45 | 11.45 | 11.45 |
| Low | 7.65 | 7.65 | 6 | 5.23 | 3.79 | 4.92 |
| Performance | +7.25% | +4.46% | -4.42% | -11.77% | +72.92% | -0.35% |
According to current financial data, SLDB stock's P/E (TTM) ratio is -4.01, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for SLDB, including P/S (N/A), P/B (2.30), and P/FCF (-4.46), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | SLDB | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -4.01 | -1.24 | -194.78 | 32.59 |
| P/S (TTM) | N/A | 3.7 | 468.69 | 5.98 |
| P/B (TTM) | 2.3 | 3.45 | -3496.43 | 5.59 |
| P/FCF (TTM) | -4.46 | 24.96 | -619.54 | 31.65 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep